Alpine Global Management’s Amedisys AMED Stock Holding History

Alpine Global Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,926	Closed	-$1.08M	–	243
2025 Q2	$1.08M	Buy	10,926 +3,886	+55%	+$368K	0.24%	61
2025 Q1	$652K	Buy	+7,040	New	+$649K	0.17%	76
2024 Q4	–	Sell	-10,000	Closed	-$965K	–	216
2024 Q3	$965K	Hold	10,000	–	–	0.23%	81
2024 Q2	$918K	Hold	10,000	–	–	0.16%	117
2024 Q1	$922K	Buy	+10,000	New	+$937K	0.18%	104
2021 Q2	–	Sell	-1,746	Closed	-$462K	–	311
2021 Q1	$462K	Buy	1,746 +697	+66%	+$197K	0.04%	172
2020 Q4	$308K	Buy	+1,049	New	+$269K	0.06%	121

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Global Management's AMED Position: Q3 2025 in Review

Alpine Global Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 10,926 shares — an estimated $1.08M sold.

Alpine Global Management first reported a position in AMED in Q4 2020 and held it in 7 quarters. The position peaked at $1.08M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Alpine Global Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Alpine Global Management sold 10,926 Amedisys shares in Q3 2025, an estimated $1.08M.
Alpine Global Management first reported a position in Amedisys in Q4 2020 and held it in 7 quarters.
Alpine Global Management's Amedisys position peaked at $1.08M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Alpine Global Management's 13F filing for Q3 2025, filed 14 Nov 2025.